Amarantus Bioscience Holdings Inc (AMBS)

[MUKA1]

So obviously very dated news, but I had forgotten just how long Dr. Urano has been working with MANF and it's potential diabetes applications.

From June 2011:
http://investor.generex.com/releasedetail.cfm?ReleaseID=583583
""The joint efforts of many players, starting from the discovery of a new use of MANF at UMass Medical School for diabetes, and the synergies of two highly committed organizations, has allowed us to generate a unique opportunity to launch a commercial development program for MANF as a biomarker of cellular stress and stressed beta cells in diabetes," said Dr. Fumihiko Urano, associate professor at the University of Massachusetts Medical School, who identified MANF's role in this area. "